Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib, Dexamethasone, and Doxil followed by Cyclophosphamide in Multiple Myeloma
NCT00148317Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jun 2005
- Primary completion
- Feb 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Weill Cornell Medicine. Started Jun 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00148317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148317.